01 1Formosa Laboratories
01 1NINTEDANIB ESYLATE
01 1Taiwan
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-07-09
Pay. Date : 2018-04-24
DMF Number : 32643
Submission : 2018-04-02
Status : Active
Type : II
20
Formosa Laboratories Inc, based in Taiwan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is NINTEDANIB ESYLATE, with a corresponding US DMF Number 32643.
Remarkably, this DMF maintains an Active status since its submission on April 02, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 09, 2018, and payment made on April 24, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
